You just read:

Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients

News provided by

Savara Pharmaceuticals

Apr 18, 2013, 08:00 ET